Skip to content

Effectiveness of Focused Pulse High Frequency Chest Wall Oscillation (HFCWO) device in patients with moderate to severe COPD

Effectiveness of Focused Pulse High Frequency Chest Wall Oscillation (HFCWO) device in patients with moderate to severe COPD

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200057912
Enrollment
Unknown
Registered
2022-03-22
Start date
2020-09-30
Completion date
Unknown
Last updated
2023-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Interventions

COPD group:Focused HFCWO
COPD groupd:PEP
COPD control:no physiotherapy

Sponsors

ASL4 Chiavarese
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 85 Years

Inclusion criteria

Inclusion criteria: copd patients level 2 3 4 gold age between 40 and 85 y

Exclusion criteria

Exclusion criteria: refused informat consent patients with asthma, in treatment with oxygen or mechanical ventilation

Design outcomes

Primary

MeasureTime frame
respiratory function parameters;

Secondary

MeasureTime frame
6 mwt;exacerbations;

Countries

italy

Contacts

Public ContactNicolini Antonello

physical Medicine and Rehabilitation

antonellonicolini@gmail.com00393495952294

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026